INX-315, CAS 2745060-92-6

Product Description: INX-315 is an orally active and selective CDK2 inhibitor that induces cell cycle arrest in the G1 phase. INX-315 reduces CDK2 substrate phosphorylation and inhibits tumor growth in a dose-dependent manner in xenograft mouse models. INX-315 may be used in cancer research[1].

Applications: Cancer-Kinase/protease

Formula: C19H21N7O3S

References: [1]Dietrich C, et al. INX-315, a selective CDK2 inhibitor, induces cell cycle arrest and senescence in solid tumors. Cancer Discov. 2023 Dec 4.

CAS Number: 2745060-92-6

Molecular Weight: 427.48

Compound Purity: 99.06

Research Area: Cancer

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: CDK

• Artikelnummer: MEXHY-162001-10.1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-162001-10.1
• Green Labware: Nein
• Verpackungseinheit: 10mM/1mL
• Mengeneinheit: STK